Blue Grotto Capital LLC reduced its position in shares of Cencora, Inc. (NYSE:COR – Free Report) by 19.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 95,000 shares of the company’s stock after selling 22,876 shares during the period. Cencora accounts for approximately 4.4% of Blue Grotto Capital LLC’s holdings, making the stock its 10th biggest position. Blue Grotto Capital LLC’s holdings in Cencora were worth $18,281,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Tilia Fiduciary Partners Inc. grew its stake in shares of Cencora by 321.2% in the 2nd quarter. Tilia Fiduciary Partners Inc. now owns 139 shares of the company’s stock valued at $27,000 after purchasing an additional 106 shares during the period. Harbour Investments Inc. boosted its position in shares of Cencora by 61.8% in the 1st quarter. Harbour Investments Inc. now owns 165 shares of the company’s stock worth $26,000 after purchasing an additional 63 shares during the last quarter. Creative Financial Designs Inc. ADV increased its stake in Cencora by 50.9% in the second quarter. Creative Financial Designs Inc. ADV now owns 175 shares of the company’s stock valued at $34,000 after purchasing an additional 59 shares in the last quarter. Cascade Investment Advisors Inc. bought a new position in Cencora during the first quarter worth about $32,000. Finally, Altshuler Shaham Ltd bought a new stake in Cencora in the 2nd quarter valued at $40,000. 93.12% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Cencora
In related news, CEO Steven H. Collis sold 25,000 shares of the stock in a transaction dated Tuesday, October 10th. The stock was sold at an average price of $185.08, for a total transaction of $4,627,000.00. Following the sale, the chief executive officer now owns 257,967 shares of the company’s stock, valued at approximately $47,744,532.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Cencora news, EVP Gina Clark sold 10,695 shares of the business’s stock in a transaction that occurred on Tuesday, October 10th. The shares were sold at an average price of $187.00, for a total value of $1,999,965.00. Following the completion of the transaction, the executive vice president now owns 16,038 shares of the company’s stock, valued at approximately $2,999,106. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Steven H. Collis sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, October 10th. The shares were sold at an average price of $185.08, for a total value of $4,627,000.00. Following the transaction, the chief executive officer now directly owns 257,967 shares in the company, valued at $47,744,532.36. The disclosure for this sale can be found here. Insiders own 20.10% of the company’s stock.
Analyst Ratings Changes
Cencora Stock Performance
Cencora stock traded down $0.74 during trading on Monday, hitting $196.83. The stock had a trading volume of 331,737 shares, compared to its average volume of 1,392,815. The stock has a market cap of $39.80 billion, a price-to-earnings ratio of 23.16, a price-to-earnings-growth ratio of 1.72 and a beta of 0.53. The stock’s 50 day moving average is $186.05 and its two-hundred day moving average is $180.22. The company has a quick ratio of 0.52, a current ratio of 0.88 and a debt-to-equity ratio of 6.22. Cencora, Inc. has a 1 year low of $147.48 and a 1 year high of $198.98.
Cencora Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 27th. Investors of record on Monday, November 13th will be paid a dividend of $0.51 per share. This is a boost from Cencora’s previous quarterly dividend of $0.49. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date is Friday, November 10th. Cencora’s dividend payout ratio is presently 23.92%.
Cencora Company Profile
Cencora, Inc sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
- Five stocks we like better than Cencora
- What Does the Consumer Price Index Measure?
- Catch the dip on Sociedad Quimica before earnings?
- Learn Technical Analysis Skills to Master the Stock Market
- Can new GPT store spur generative AI monetization?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Energy looks to dominate markets with 3 oil and gas stocks
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.